Waddell & Reed Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $54.3M | Sell |
|
|||||
|
2020
Q4 | $95.6M | Buy |
|
|||||
|
2020
Q3 | $89.8M | Sell |
|
|||||
|
2020
Q2 | $106M | Sell |
|
|||||
|
2020
Q1 | $103M | Sell |
|
|||||
|
2019
Q4 | $131M | Buy |
|
|||||
|
2019
Q3 | $80.3M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $39.9M | Sell |
|
|||||
|
2015
Q3 | $64.5M | Sell |
|
|||||
|
2015
Q2 | $79.7M | Buy |
|
|||||
|
2015
Q1 | $84.5M | Sell |
|
|||||
|
2014
Q4 | $266M | Buy |
|
|||||
|
2014
Q3 | $41.6M | Sell |
|
|||||
|
2014
Q2 | $73.7M | Buy |
|
|||||
|
2014
Q1 | $69.9M | Buy |
|
|||||
|
2013
Q4 | $68.3M | Buy |
|
|||||
|
2013
Q3 | $61.5M | Buy |
|
|||||
|
2013
Q2 | $57.1M | Buy |
|